Biosergen AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
Cash & Equivalents	15.37	50.61	1.88	29.34	21.67	Upgrade
Cash & Short-Term Investments	15.37	50.61	1.88	29.34	21.67	Upgrade
Cash Growth	-69.64%	2587.84%	-93.58%	35.44%	-	Upgrade
Other Receivables	6.21	1.95	4.93	4.02	7.47	Upgrade
Receivables	6.21	1.95	4.93	4.02	7.47	Upgrade
Prepaid Expenses	-	0.46	0.39	0.43	0.35	Upgrade
Total Current Assets	21.58	53.02	7.2	33.79	29.49	Upgrade
Total Assets	21.58	53.02	7.2	33.79	29.49	Upgrade
Accounts Payable	-	2.38	1.7	6.81	6.75	Upgrade
Accrued Expenses	-	2.4	3.26	4	2.41	Upgrade
Other Current Liabilities	11.09	0.03	0.13	0.18	0.1	Upgrade
Total Current Liabilities	11.09	4.81	5.09	11	9.25	Upgrade
Other Long-Term Liabilities	2.37	-	-	-	-0	Upgrade
Total Liabilities	13.46	4.81	5.09	11	9.25	Upgrade
Common Stock	8.12	5.87	1.27	1.06	0.7	Upgrade
Comprehensive Income & Other	-	42.34	0.85	21.73	19.53	Upgrade
Shareholders' Equity	8.12	48.21	2.12	22.79	20.23	Upgrade
Total Liabilities & Equity	21.58	53.02	7.2	33.79	29.49	Upgrade
Net Cash (Debt)	15.37	50.61	1.88	29.34	21.67	Upgrade
Net Cash Growth	-69.64%	2587.84%	-93.58%	35.44%	-	Upgrade
Net Cash Per Share	6.54	21.09	3.69	93.93	77.02	Upgrade
Filing Date Shares Outstanding	2.35	2.35	0.51	0.42	0.28	Upgrade
Total Common Shares Outstanding	2.35	2.35	0.51	0.42	0.28	Upgrade
Working Capital	10.48	48.21	2.12	22.79	20.23	Upgrade
Book Value Per Share	3.46	20.53	4.17	53.72	72.00	Upgrade
Tangible Book Value	8.12	48.21	2.12	22.79	20.23	Upgrade
Tangible Book Value Per Share	3.46	20.53	4.17	53.72	72.00	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.